Redeye updates estimates and valuation on GiG post its Q3-results where the outcome was close to our expectations. The company maintains it 2022 guidance impying a strong year-end and we make limited changes to our estimates.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/